(Q38009581)

English

The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence

scientific article published on 10 May 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

object named as

Carlos Rodrigo

4

0 references

author name string

Vytautas Usonis

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Inga Ivaskeviciene

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Ulrich Desselberger

3

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Pediatric ROTavirus European CommiTtee (PROTECT)

5

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

10 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

4596-4605

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Global mortality associated with rotavirus disease among children in 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Burden of childhood rotavirus disease on health systems in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

The Clinical Burden of Rotavirus Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

The ever-changing landscape of rotavirus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotaviruses and rotavirus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Genetic and Antigenic Diversity of Human Rotaviruses: Potential Impact on Vaccination Programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus Epidemiology and Surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus infections and vaccines: burden of illness and potential impact of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Recommendations for rotavirus vaccination: A worldwide perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Global impact of rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Influence of potential protective mechanisms on the development of live rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Immune responses to rotavirus infection and vaccination and associated correlates of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus types in Europe and their significance for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Report of the second European expert meeting on rotavirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus gastroenteritis in Finnish children in 2006–2008, at the introduction of rotavirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Report of the 'European Expert Meeting on Rotavirus Vaccination', Tampere, Finland, 19-20 May 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Detection and characterization of group A rotaviruses in children hospitalized with acute gastroenteritis in Norway, 2006-2008.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Molecular and clinical characterization of rotavirus from diarrheal infants admitted to pediatric emergency units in france.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

A hospital based study on inter- and intragenotypic diversity of human rotavirus A VP4 and VP7 gene segments, Germany.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Genetic diversity and zoonotic potential of human rotavirus strains, 2003-2006, Hungary

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Changing profile of rotavirus in Ireland: predominance of P[8] and emergence of P[6] and P[9] in mixed infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Molecular epidemiology of rotaviruses in Bulgaria: annual shift of the predominant genotype.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Genetic characterization of Bulgarian rotavirus isolates and detection of rotavirus variants: challenges for the rotavirus vaccine program?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Frequency, clinical characteristics, and genotype distribution of rotavirus gastroenteritis in Greece (2007-2008).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Emergence of unusual human rotavirus strains in Salento, Italy, during 2006-2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus genotypes in children in the Basque Country (northern Spain) over a 13-year period (July 1996-June 2009).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Effect of rotavirus vaccination on circulating virus strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus genotypes circulating in Brazil before national rotavirus vaccination: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Group A rotavirus genotypes and the ongoing Brazilian experience: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Rotavirus disease and vaccination: impact on genotype diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Impact of rotavirus vaccination: the importance of monitoring strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Immunity and correlates of protection for rotavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

Genome rearrangements of rotaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.097

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.04.097

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38009581&oldid=1737219144"